Target intelligence / Profile preview

Post-GPI attachment to proteins factor 6 (PGAP6)

Target
PGAP6
Molecular classification
Enzyme, Phospholipase A2 family, Transmembrane protein (CREST superfamily)
01

Overview

Post-GPI attachment to proteins factor 6 (PGAP6) is a transmembrane phospholipase A2 enzyme involved in post-translational lipid remodeling of glycosylphosphatidylinositol (GPI) anchors. It specifically removes a fatty acyl-chain at the sn-2 position of the GPI anchor, which is essential for the maturation and function of a subset of GPI-anchored proteins. PGAP6 has a large extracellular N-terminal domain and seven transmembrane domains, and belongs to the CREST superfamily of lipases. Its enzymatic activity is highly specific, targeting only a limited set of GPI-anchored proteins, notably triggering the release (shedding) of CRIPTO, a GPI-anchored co-receptor critical for Nodal signaling in embryonic development. By enabling the release of soluble CRIPTO, PGAP6 finely regulates intercellular signaling events, particularly in early embryogenesis. Pathogenic variants in PGAP6 have been associated with neurological and developmental disorders, and dysfunction in GPI-anchor processing can broadly affect cell signaling and development[1][2][5][6].

Other names
TMEM6TMEM8TMEM8AGPI-PLA2M83GPI processing phospholipase A2Protein M83Transmembrane protein 6Transmembrane protein 8Transmembrane protein 8Afive-span transmembrane protein M83post-glycosylphosphatidylinositol attachment to proteins 6
02

Biological functions

Lipid remodeling during GPI-anchor maturationGPI-specific phospholipase A2 activityShedding of selected GPI-anchored proteins from the cell surfaceModulation of Nodal signaling via CRIPTO release
03

Disease associations

Developmental disorders (e.g. Developmental and epileptic encephalopathy 80)Potential involvement in Nodal signaling–related embryonic development abnormalities

Beyond the preview

Go deeper on Post-GPI attachment to proteins factor 6 (PGAP6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Post-GPI attachment to proteins factor 6 (PGAP6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call